By Cecilia Butini

 

Merck KGaA said Monday that it has appointed Belen Garijo as deputy chief executive and vice chairman of the executive board effective immediately.

Ms. Garijo joined Merck in 2011 as chief operating officer of the biopharma business and was named to the board in 2015, the German pharmaceuticals and life sciences company said. She is currently CEO of the healthcare business and heads the corporate functions human resources and environment, health, safety, security, quality.

The company also said Udit Batra, chief executive of the life sciences branch, is leaving the company to pursue other opportunities.

Christos Ross will be in charge of the life science business sector on an interim basis. Merck Chief Financial Officer Marcus Kuhnert will take over additional executive board responsibility for Information Technology, the company said.

 

Write to Cecilia Butini at cecilia.butini@wsj.com

 

(END) Dow Jones Newswires

July 13, 2020 09:41 ET (13:41 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more Merck KGaA (PK) Charts.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more Merck KGaA (PK) Charts.